Published on Oct 08, 2021
DRDO Develops COVID-19 Antibody Detection Kit : Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit ‘DIPCOVAN’, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance.
The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent.
The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based at New Delhi.
The DIPCOVAN kit was developed indigenously by the scientists, followed by extensive validation on more than 1,000 patient samples at various COVID designated hospitals in Delhi. Three batches of the product were validated during last one year. The antibody detection kit is approved by Indian Council of Medical Research (ICMR) in April 2021.
In May 2021, the product received the regulatory approval from the Drugs Controller General of India (DCGI), Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, to manufacture for sale and distribution.
DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens. It offers a significantly faster turn-around-time as it requires just 75 minutes to conduct the test without any cross reactivity with other diseases. The kit has a shelf life of 18 months.
Industry partner Vanguard Diagnostics Pvt. Ltd will commercially launch the product during the first week of June 2021. Readily available stock at the time of launch will be 100 kits (approx. 10,000 tests) with a production capacity of 500 kits/month after the launch. It is expected to be available at about Rs 75 per test.
The kit will be very useful for understanding COVID‐19 epidemiology and assessing an individual’s previous SARS‐CoV‐2 exposure.
Raksha Mantri Rajnath Singh has appreciated the efforts of DRDO and the industry in developing the kit at the time of need.
Secretary Department of Defence R&D & Chairman DRDO Dr G Satheesh Reddy complimented the teams involved in developing the kit and said the initiative will help the people during the pandemic.
The Price of Coviself Corona Test Kit will be 250 Rupees. It will be flourished in the Indian Market by the next week. Mylab director stated that initially Coviself will be in around 9 lakh pharma shops. He also added that we are thriving to cover 90 percent pin codes in the country. This is very convenient to use by user through Myab’s AI-powered mobile app and get their result at instant.
Well anyone who can use it who has mild, moderate, or severe symptoms of Covid-19. But initially, ICMR is insisting that only symptomatic patients should go for self-test at home. Mylab Covid Test will bring down the burden on laboratories. As well as this is super fast. Your Covid-19 test is now in 15 minutes time span. Whereas earlier it may take 72 hours to get the report.
Mylab Covid 19 Rapid Antigen Kit comes with the manual and instruments from which you can carry the test from your home only. Mylab Discovery Solutions Coviself Kit Use is safe to use and for that, you have to download Mylab App from your android phone and apple phone. Download this application and keep it till the test has not proceeded further. This application will help you till the test is done on the patient.
To know more about Mylab Coviself Kit price you can check the application. As you will get the manual along Coviself Corona Test kit but in case you want more details you can get it from the application. Now after you perform the test, you need to upload the test results on the application. This is the last step but the important from all. Remember that once you get the result positive from the kit, you do not need to go for RTPCR. If any individual comes negative then you might get the RTPCR done.
